Our work revolves around providing hope for patients.
About Us
Our mission is to transform cancer patients
into cancer survivors
Investors
We are moving forward confidently to realize our mission and create value
We are committed to providing hope in the face of despair by developing a tumor-targeting drug (SONALA-001) together with MR-guided focused ultrasound as sonodynamic therapy (SDT). This combination has the potential to be a safe and effective noninvasive treatment for cancer.
SonALAsense is the first company to advance SDT into clinical trials.
Soundly Defeating Cancer
SDT is a Platform Technology
SonALAsense is pursuing a Pipeline of additional indications utilizing SDT to treat multiple tumor types.
Investors
We are moving forward confidently to realize our mission and create value
About Us
Our mission is to transform cancer patients into cancer survivors
Our science targets cancer's own needs to cause it to destroy itself.
SDT metabolically targets cancer cells causing immediate and programmed cell death.
Clinical trials now recruiting, Contact Us to learn more about eligibility.